A Heterotrimeric G
-protein Controls Autophagic Sequestration in the Human Colon Cancer Cell Line HT-29 (*)
- Eric Ogier-Denis(1),
- Alain Couvineau(1),
- Jean José Maoret(1),
- Jean Jacques Houri(1),
- Chantal Bauvy(1),
- Daniela De Stefanis(2),
- Ciro Isidoro(2),
- Marc Laburthe(1) and
- Patrice Codogno(1)(§)
- From the (1)From INSERM U410, Neuroendocrinologie et Biologie Cellulaire Digestives, Faculté de Médecine Xavier Bichat, 16 rue Henri Huchard, 75018 Paris, France and
- (2)Dipartimento di Medicina ed Oncologia Sperimentale, Sez. Patologia Generale, Università di Torino, Corso Raffaello 30, 10125 Torino, Italy
- ↵§ To whom correspondence should be addressed. Tel.: 33-1-44-85-61-34; Fax: 33-1-42-28-87-65.
Abstract
Human colon cancer HT-29 cells exhibit a differentiation-dependent autophagic-lysosomal pathway that is responsible for the
degradation of a pool of newly synthesized N-linked glycoproteins in undifferentiated cells. In the present study, we have investigated the molecular control of this
degradative pathway in undifferentiated HT-29 cells. For this purpose, we have modulated the function and expression of the
heterotrimeric G-proteins (Gs and Gi) in these cells. After pertussis toxin treatment which ADP-ribosylates heterotrimeric Gi-proteins, we observed an inhibition of autophagic sequestration and the complete restoration of the passage of N-linked glycoproteins through the Golgi complex. In contrast, autophagic sequestration was not reduced by cholera toxin, which
acts on heterotrimeric Gs-proteins. Further insights on the nature of the pertussis toxin-sensitive α subunit controlling autophagic sequestration
were obtained by cDNA transfections of αi subunits. Overexpression of the α
subunit increased autophagic sequestration and degradation in undifferentiated cells, whereas overexpression of the α
subunit, the only other pertussis toxin-sensitive α subunit expressed in HT-29 cells, did not alter the rate of autophagy.
Footnotes
-
↵* This work was supported by institutional funding from INSERM and from the Consiglio Nazionale delle Ricerche (CNR), and by grants from the Association pour la Recherche sur le Cancer (Grant 6014 to P. C.), AIRC (Milan), MURST (Rome), special project ACRO of the CNR (Rome), and a fellowship from the Ligue Nationale contre le Cancer (to J. J. H.). This work is part of a bilateral project of INSERM/CNR. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Received August 17, 1994.
- Revision received October 25, 1994.
- © 1995 by The American Society for Biochemistry and Molecular Biology, Inc.











